Halo gets investment from private equity group; 1.5 million bottles of eye drops recalled;

> Afghanistan blames Pakistani counterfeiters and corrupt border officials for a flood of fake meds. Story

> Argos Therapeutics ($ARGS) has struck a deal for Saint-Gobain's Performance Plastics division to design disposables for use in the manufacturing of Argos' lead product candidate. Release

> Workers have gone on strike at an Arvind Remedies plant in Tamil Nadu, India. Report

> Private investment group SK Capital Partners has taken a controlling interest in Whippany, NJ-based contract manufacturer Halo Pharmaceutical. Release

And Finally... K.C. Pharmaceuticals of Pomona, CA, is recalling about 1.5 million bottles of an over-the-counter eye drop solution being sold by retailers across the U.S. because they were stored at a noncompliant facility in Italy. Report

Suggested Articles

The eight-year deal will initially cover lupus drug Benlysta and could expand to other GSK specialty-care products in the future.

With a new £131 million contribution from the U.K. government, VMIC aims to both speed up and expand on its prior ambitions.

Pricing controversies shouldn't overshadow Phlow's promise to provide low-cost drugs to address COVID-19, says the CEO of partner Civica Rx.